FDA 483 - Chartwell Pharmaceuticals LLC - May 24, 2023

Chartwell Pharmaceuticals LLC, a drug manufacturer in Congers, NY, was inspected by the FDA and received six observations. The inspection revealed significant deficiencies in stability data, quality control unit procedures, employee training, production hold times, and facility/equipment readiness for new product manufacturing. These issues indicate a broad lack of adherence to good manufacturing practices.